Admedus successfully tests its 3D printed TAVR heart valve on sheep

Queensland-based medical technologies company, Admedus, has announced new progress in the development of its patented Transcatheter Aortic Valve Replacement (TAVR) project. The company has commenced animal trials by completing the first successful live implantation of its unique single-piece aortic heart valve in a sheep.

Powered by WPeMatico

Close Menu